Table 5 The detail of PRA and DSA in the study (n = 93)
From: The fraction of sensitization among lung transplant recipients in a transplant center in Japan
DSA | ||||
|---|---|---|---|---|
Identification | MFI | C1q-binding | ||
PRA class 1+/class2- | 9 | |||
PRA > 25% | 3 | |||
Non-DSA anti-HLA antibodies | 7 | |||
DSA (MFI > 1000) | 2 | Cw4 | 1243 | negative |
B52, B59 | 4249, 2860 | negative | ||
PRA class 1−/class2+ | 5 | |||
PRA > 25% | 0 | |||
Non-DSA anti-HLA antibodies | 4 | |||
DSA (MFI > 1000) | 1 | DR4 | 1248 | negative |
PRA class 1+/class2+ | 9 | |||
PRA > 25% | 7 | |||
Non-DSA anti-HLA antibodies | 7 | |||
DSA (MFI > 1000) | 2 | DR4 | 1137 | negative |
DQ9 | 4091 | negative | ||